London, United Kingdom

Peter Henri Sonksen


Average Co-Inventor Count = 4.1

ph-index = 6

Forward Citations = 186(Granted Patents)


Location History:

  • London, SE1 7EH, GB (1995)
  • London, DE (1998)
  • London, GB (1995 - 2006)

Company Filing History:


Years Active: 1995-2006

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Peter Henri Sonksen: Innovator in Pharmaceutical Actives

Introduction

Peter Henri Sonksen is a notable inventor based in London, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of hepatoselective pharmaceutical actives. With a total of 6 patents to his name, Sonksen's work has the potential to impact insulin replacement therapy and other medical applications.

Latest Patents

Sonksen's latest patents include innovative formulations that provide analogues of pharmaceutical actives with molecular weights less than 25,000 Daltons. These analogues are designed to be covalently linked to pendant molecular groups, resulting in active complexes that exceed 25,000 Daltons in the circulatory system. His inventions focus on creating hepatoselective analogues, particularly insulin analogues, which can be utilized in insulin replacement therapy.

Career Highlights

Throughout his career, Sonksen has worked with various organizations, including the Deutsches Wollforschungsinstitut. His expertise in pharmaceutical sciences has allowed him to develop groundbreaking technologies that enhance the efficacy of drug delivery systems.

Collaborations

Sonksen has collaborated with notable professionals in his field, including Fariba Shojaee-Moradi and Dietrich Brandenburg. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Peter Henri Sonksen is a distinguished inventor whose work in pharmaceutical actives has the potential to revolutionize treatment methods, particularly in insulin therapy. His innovative patents and collaborations highlight his commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…